Diebold Nixdorf, Incorporated (DBD)
(Delayed Data from NYSE)
$56.89 USD
-3.16 (-5.26%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $56.79 -0.10 (-0.18%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
DBD 56.89 -3.16(-5.26%)
Will DBD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DBD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DBD
Diebold Nixdorf, Incorporated (DBD) Rises Higher Than Market: Key Facts
Is It Worth Investing in Diebold Nixdorf, Incorporated (DBD) Based on Wall Street's Bullish Views?
DBD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Investors Heavily Search Diebold Nixdorf, Incorporated (DBD): Here is What You Need to Know
Diebold Nixdorf, Incorporated (DBD) Dips More Than Broader Market: What You Should Know
Here is What to Know Beyond Why Diebold Nixdorf, Incorporated (DBD) is a Trending Stock
Other News for DBD
DBD Fell Below 50 Day Moving Average on September 19
Is DBD set to rally? Crossed Above 50 Day Moving Average shows up after gaining 1.61%
Major Shareholder Sells Off Diebold Nixdorf Stock in a Multi-Million Dollar Move!
Is DBD lining up for a decline? 50 Day Moving Average Resistance shows up after sinking 1.19%
DBD Fell Below 50 Day Moving Average on September 16